Skip to main content
Top
Published in: BMC Health Services Research 1/2008

Open Access 01-12-2008 | Research article

Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: Lessons learned from a health care services study

Authors: Theodora Zachariadou, Henri EJH Stoffers, Costas A Christophi, Anastasios Philalithis, Christos Lionis

Published in: BMC Health Services Research | Issue 1/2008

Login to get access

Abstract

Background

Recent guidelines recommend assessment and treatment of the overall risk for cardiovascular disease (CVD) through management of multiple risk factors in patients at high absolute risk. The aim of our study was to assess the level of cardiovascular risk in patients with known risk factors for CVD by applying the SCORE risk function and to study the implications of European guidelines on the use of treatment and goal attainment for blood pressure (BP) and lipids in the primary care of Cyprus.

Methods

Retrospective chart review of 1101 randomly selected patients with type 2 diabetes mellitus (DM2), or hypertension or hyperlipidemia in four primary care health centres. The SCORE risk function for high-risk regions was used to calculate 10-year risk of cardiovascular fatal event. Most recent values of BP and lipids were used to assess goal attainment to international standards. Most updated medications lists were used to compare proportions of current with recommended antihypertensive and lipid-lowering drug (LLD) users according to European guidelines.

Results

Implementation of the SCORE risk model labelled overall 39.7% (53.6% of men, 31.3% of women) of the study population as high risk individuals (CVD, DM2 or SCORE ≥5%). The SCORE risk chart was not applicable in 563 patients (51.1%) due to missing data in the patient records, mostly on smoking habits. The LDL-C goal was achieved in 28.6%, 19.5% and 20.9% of patients with established CVD, DM2 (no CVD) and SCORE ≥5%, respectively. BP targets were achieved in 55.4%, 5.6% and 41.9% respectively for the above groups. There was under prescription of antihypertensive drugs, LLD and aspirin for all three high risk groups.

Conclusion

This study demonstrated suboptimal control and under-treatment of patients with cardiovascular risk factors in the primary care in Cyprus. Improvement of documentation of clinical information in the medical records as well as GPs training for implementation and adherence to clinical practice guidelines are potential areas for further discussion and research.
Literature
1.
go back to reference De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D: Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003, 24: 1601-1610. 10.1016/S0195-668X(03)00347-6.CrossRefPubMed De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D: Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003, 24: 1601-1610. 10.1016/S0195-668X(03)00347-6.CrossRefPubMed
2.
go back to reference Graham IM: Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol. 2005, 20: 430-439. 10.1097/01.hco.0000176405.56119.54.CrossRefPubMed Graham IM: Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol. 2005, 20: 430-439. 10.1097/01.hco.0000176405.56119.54.CrossRefPubMed
3.
go back to reference Health and Hospital Statistics: Statistical Service of Cyprus. 2004, 1: 284-285. Health and Hospital Statistics: Statistical Service of Cyprus. 2004, 1: 284-285.
4.
go back to reference Anderson KM, Odell PM, Wilson PWF, Kannel WB: Cardiovascular risk profiles. Am Heart J. 1990, 121: 293-298. 10.1016/0002-8703(91)90861-B.CrossRef Anderson KM, Odell PM, Wilson PWF, Kannel WB: Cardiovascular risk profiles. Am Heart J. 1990, 121: 293-298. 10.1016/0002-8703(91)90861-B.CrossRef
5.
go back to reference Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB: An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003, 57: 634-638. 10.1136/jech.57.8.634.CrossRefPubMedPubMedCentral Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB: An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003, 57: 634-638. 10.1136/jech.57.8.634.CrossRefPubMedPubMedCentral
6.
go back to reference Hense HW, Schulte H, Lowel H, Assmann G, Keil U: Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003, 24: 937-945. 10.1016/S0195-668X(03)00081-2.CrossRefPubMed Hense HW, Schulte H, Lowel H, Assmann G, Keil U: Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003, 24: 937-945. 10.1016/S0195-668X(03)00081-2.CrossRefPubMed
7.
go back to reference Menotti A, Puddu PE, Lanti M: Comparison of the Framingham risk function based coronary chart with risk function from an Italian population study. Eur Heart J. 2000, 21: 365-370. 10.1053/euhj.1999.1864.CrossRefPubMed Menotti A, Puddu PE, Lanti M: Comparison of the Framingham risk function based coronary chart with risk function from an Italian population study. Eur Heart J. 2000, 21: 365-370. 10.1053/euhj.1999.1864.CrossRefPubMed
8.
go back to reference Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, on behalf of the SCORE project group: Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003, 24: 987-1003. 10.1016/S0195-668X(03)00114-3.CrossRefPubMed Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, on behalf of the SCORE project group: Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003, 24: 987-1003. 10.1016/S0195-668X(03)00114-3.CrossRefPubMed
9.
go back to reference Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori S, Pyörälä K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte Op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL: European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil. 2007, 14 (S2): S1-S113. 10.1097/01.hjr.0000277983.23934.c9.CrossRefPubMed Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori S, Pyörälä K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte Op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL: European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil. 2007, 14 (S2): S1-S113. 10.1097/01.hjr.0000277983.23934.c9.CrossRefPubMed
10.
go back to reference Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright J, Roccella E, the National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright J, Roccella E, the National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed
11.
go back to reference Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC: The 1997 American Diabetes Association and 1999 World Health Organisation Criteria for Hyperglycaemia in the Diagnosis and Prediction of Diabetes. Diabetes Care. 2000, 23: 1108-1112. 10.2337/diacare.23.8.1108.CrossRefPubMed Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC: The 1997 American Diabetes Association and 1999 World Health Organisation Criteria for Hyperglycaemia in the Diagnosis and Prediction of Diabetes. Diabetes Care. 2000, 23: 1108-1112. 10.2337/diacare.23.8.1108.CrossRefPubMed
12.
go back to reference International Statistical Classification of Diseases and Related Health Problems. 10th revision. 1992, WHO: Geneva, 1. International Statistical Classification of Diseases and Related Health Problems. 10th revision. 1992, WHO: Geneva, 1.
15.
go back to reference Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J: Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modeling study. BMJ. 2005, 331: 551-10.1136/bmj.38555.648623.8F.CrossRefPubMedPubMedCentral Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J: Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modeling study. BMJ. 2005, 331: 551-10.1136/bmj.38555.648623.8F.CrossRefPubMedPubMedCentral
16.
go back to reference Harz I, Njølstad I, Eggen AE: Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Trømso study 2001. Eur Heart J. 2005, 26: 2673-2680. 10.1093/eurheartj/ehi556.CrossRef Harz I, Njølstad I, Eggen AE: Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Trømso study 2001. Eur Heart J. 2005, 26: 2673-2680. 10.1093/eurheartj/ehi556.CrossRef
17.
go back to reference Brekke M, Rekdal M, Straand J: Which population groups should be targeted for cardiovascular prevention? A modeling study based on the Norwegian Hordaland Health Study (HUSK). Scand J Prim Health Care. 2007, 25: 105-111. 10.1080/02813430701241087.CrossRefPubMedPubMedCentral Brekke M, Rekdal M, Straand J: Which population groups should be targeted for cardiovascular prevention? A modeling study based on the Norwegian Hordaland Health Study (HUSK). Scand J Prim Health Care. 2007, 25: 105-111. 10.1080/02813430701241087.CrossRefPubMedPubMedCentral
18.
go back to reference Fornasini M, Brotons C, Sellarès J, Martinez M, Galán ML, Sáenz I, da Pena JM: Consequences of using different methods to assess cardiovascular risk in primary care. Fam Pract. 2006, 23: 28-33. 10.1093/fampra/cmi092.CrossRefPubMed Fornasini M, Brotons C, Sellarès J, Martinez M, Galán ML, Sáenz I, da Pena JM: Consequences of using different methods to assess cardiovascular risk in primary care. Fam Pract. 2006, 23: 28-33. 10.1093/fampra/cmi092.CrossRefPubMed
19.
go back to reference Turon JM, Librero J, Diaz GJ, Garcia JJ, Beltral C, Abal F, on behalf of the Redimer study group (SEMFYC): Auditing secondary prevention of ischemic heart disease in rural areas of Spain: an opportunity for improvement. Eur J Gen Pract. 2006, 12: 156-162. 10.1080/13814780601009786.CrossRefPubMed Turon JM, Librero J, Diaz GJ, Garcia JJ, Beltral C, Abal F, on behalf of the Redimer study group (SEMFYC): Auditing secondary prevention of ischemic heart disease in rural areas of Spain: an opportunity for improvement. Eur J Gen Pract. 2006, 12: 156-162. 10.1080/13814780601009786.CrossRefPubMed
20.
go back to reference Straka RJ, Taheri R, Cooper SL, Tan AWH, Smith JC: Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy. 2001, 21: 818-827. 10.1592/phco.21.9.818.34563.CrossRefPubMed Straka RJ, Taheri R, Cooper SL, Tan AWH, Smith JC: Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy. 2001, 21: 818-827. 10.1592/phco.21.9.818.34563.CrossRefPubMed
21.
go back to reference Hartz I, Eggen AE, Grimsgaard S, Skjold F, Njølstad I: Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population based study: the Trømso study 2001. Eur J Clin Pharmacol. 2004, 60: 643-649. 10.1007/s00228-004-0827-z.CrossRefPubMed Hartz I, Eggen AE, Grimsgaard S, Skjold F, Njølstad I: Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population based study: the Trømso study 2001. Eur J Clin Pharmacol. 2004, 60: 643-649. 10.1007/s00228-004-0827-z.CrossRefPubMed
22.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, Sans S: Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001, 357: 995-1001. 10.1016/S0140-6736(00)04235-5.CrossRef Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, Sans S: Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001, 357: 995-1001. 10.1016/S0140-6736(00)04235-5.CrossRef
23.
go back to reference Johnson ML, Pietz K, Battleman DS, Beyth RJ: Therapeutic goal attainment in patients with hypertension and dyslipidemia. Med Care. 2006, 44: 39-46. 10.1097/01.mlr.0000188982.25397.37.CrossRefPubMed Johnson ML, Pietz K, Battleman DS, Beyth RJ: Therapeutic goal attainment in patients with hypertension and dyslipidemia. Med Care. 2006, 44: 39-46. 10.1097/01.mlr.0000188982.25397.37.CrossRefPubMed
24.
go back to reference Pearson TA, Laurora I, Chu H, Kafonek S: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000, 160: 459-467. 10.1001/archinte.160.4.459.CrossRefPubMed Pearson TA, Laurora I, Chu H, Kafonek S: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000, 160: 459-467. 10.1001/archinte.160.4.459.CrossRefPubMed
25.
go back to reference Vaccaro O, Boemi M, Cavalot F, De Feo P, Miccoli R, Patti L, Rivellese AA, Trovati M, Ardigò D, Zavaroni I: The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis. 2008, 198 (2): 396-402. 10.1016/j.atherosclerosis.2007.10.026.CrossRefPubMed Vaccaro O, Boemi M, Cavalot F, De Feo P, Miccoli R, Patti L, Rivellese AA, Trovati M, Ardigò D, Zavaroni I: The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis. 2008, 198 (2): 396-402. 10.1016/j.atherosclerosis.2007.10.026.CrossRefPubMed
26.
go back to reference Gikas A, Sotiropoulos A, Politakis P, Spanou E, Apostolou O, Pappas S: Level of glycemic and lipid control among diabetic patients in Greek primary care. Eur J Gen Pract. 2006, 12: 181-182. 10.1080/13814780600888495.CrossRefPubMed Gikas A, Sotiropoulos A, Politakis P, Spanou E, Apostolou O, Pappas S: Level of glycemic and lipid control among diabetic patients in Greek primary care. Eur J Gen Pract. 2006, 12: 181-182. 10.1080/13814780600888495.CrossRefPubMed
27.
go back to reference McFarlane S, Jacober S, Winer N, Kaur J, Castro J, Wui M, Gliwa A, Von Gizycki H, Sowers J: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002, 25: 718-723. 10.2337/diacare.25.4.718.CrossRefPubMed McFarlane S, Jacober S, Winer N, Kaur J, Castro J, Wui M, Gliwa A, Von Gizycki H, Sowers J: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002, 25: 718-723. 10.2337/diacare.25.4.718.CrossRefPubMed
28.
go back to reference Le Floch JP, Thervet F, Desriac I, Boyer JF, Simon D: Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab. 2000, 26: 43-49.PubMed Le Floch JP, Thervet F, Desriac I, Boyer JF, Simon D: Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab. 2000, 26: 43-49.PubMed
29.
go back to reference Belle Brown J, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M: The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract. 2002, 19: 344-349. 10.1093/fampra/19.4.344.CrossRef Belle Brown J, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M: The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract. 2002, 19: 344-349. 10.1093/fampra/19.4.344.CrossRef
Metadata
Title
Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: Lessons learned from a health care services study
Authors
Theodora Zachariadou
Henri EJH Stoffers
Costas A Christophi
Anastasios Philalithis
Christos Lionis
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2008
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-8-148

Other articles of this Issue 1/2008

BMC Health Services Research 1/2008 Go to the issue